(Q41139751)

27 September 2017

title

Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH). (English)

1 reference

27 September 2017

9

1 reference

27 September 2017

Zarandi M

1

1 reference

27 September 2017

Kovacs M

2

1 reference

27 September 2017

Horvath JE

3

1 reference

27 September 2017

Toth K

4

1 reference

27 September 2017

Halmos G

5

1 reference

27 September 2017

Groot K

6

1 reference

27 September 2017

Nagy A

7

1 reference

27 September 2017

Kele Z

8

1 reference

27 September 2017

publication date

1 January 1997

1 reference

27 September 2017

1 reference

27 September 2017

volume

18

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

423-430

1 reference

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Synthesis, biological activity and conformational analysis of cyclic GRF analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Affinity of human growth hormone-releasing factor (1-29)NH2 analogues for GRF binding sites in rat adenopituitary.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Amphiphilic Secondary Structure: Design of Peptide Hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Inhibition of GH release of rats by new potent antagonists of growth hormone-releasing hormone (GH-RH).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Inhibition of pulsatile growth hormone (GH) secretion and somatic growth in immature rats with a synthetic GH-releasing factor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

The application of the principles of statistical analysis to the biological assay of hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

A method for evaluation of activity of antagonistic analogs of growth hormone-releasing hormone in a superfusion system

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted with a single D-amino acid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Synthetic analogs of growth hormone-releasing factor with antagonistic activity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Involvement of IGF-II in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Interaction between hypothalamic peptides in a superfused pituitary cell system

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Insulin-like growth factors: the unrecognised oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Potent agonists of growth hormone-releasing hormone. Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900344-0

7 January 2021

10.1016/S0196-9781(96)00344-0

Identifiers

DOI

1 reference

27 September 2017

1 reference